TriNetX Names Carnell Elliott Chief Commercial Officer
The clinical research network appointed Elliott to lead its sales, global healthcare partnerships and marketing teams.
Updated on Nov. 17, 2026 in People

TriNetX has appointed Carnell Elliott as Chief Commercial Officer, reporting to Chief Executive Officer August Calhoun. Elliott will lead the company's sales, global healthcare partnerships and marketing teams.
Why it matters
The appointment places a commercial leader with prior revenue and sales experience at healthcare technology firms in charge of growing TriNetX's partnerships. The network operates across more than 14,200 clinical sites in 20+ countries, making commercial leadership central to its expansion.
Elliott previously grew bookings at Change Healthcare from roughly $50 million to $200 million in total contract value. TriNetX's network spans more than 14,200 clinical sites in 20+ countries, though the company has not disclosed how the appointment will affect its commercial targets.
The players
TriNetX
TriNetX is a health research network that connects clinical sites and healthcare organizations to support data-driven research and trial work.
Carnell Elliott
Carnell Elliott is a commercial and sales executive with prior leadership roles at Henry Schein One, Change Healthcare, Built Technologies and Dell Technologies.
August Calhoun
August Calhoun is the chief executive officer of TriNetX, to whom Elliott will report.
The details
Elliott joins TriNetX from Henry Schein One, where he served as Vice President of Revenue and led a commercial team spanning sales, account management, customer success and market development. Earlier, he was Vice President of Sales and Market Development at Change Healthcare, and he has held leadership roles at Built Technologies and Dell Technologies.
Timeline
Nov. 17, 2026: TriNetX announced Elliott's appointment as Chief Commercial Officer.
Market Landscape
The hire fits a pattern in which healthcare technology companies recruit commercial leaders with track records at peer vendors such as Change Healthcare and Henry Schein One. As clinical data networks compete for pharmaceutical and health-system partnerships, sales leadership has become a central lever for growth.
For healthcare organizations and research partners, the appointment signals a shift in TriNetX's commercial direction that could affect partnership terms and access to its clinical site network. Buyers evaluating health data platforms may see changes in pricing or engagement models as the new commercial team takes shape.
The takeaway
Leadership changes in commercial roles often signal where a health technology company intends to focus its growth. Organizations working with TriNetX may want to watch how partnership and sales priorities evolve under its new Chief Commercial Officer.
Further reading
For more executive moves in the sector, see People coverage across Cambridge business news.
Source note: This article includes information reported by The Queenslander.






